Jim Cramer Blesses a Caller’s Speculative Investment in Xeris Biopharma

17 hours ago 1

Syeda Seirut Javed

Fri, June 12, 2026 astatine 9:45 AM CDT 1 min read

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) was among the stocks Jim Cramer commented on, saying that tech stocks cannot beryllium trusted to pb anymore. When a caller mentioned that XERS is their speculative investment, Cramer said:

I cognize it due to the fact that it's injectables… But I volition archer you this: that's precisely what I privation you to do. That's precisely what you need. But 1 of them, conscionable 1 that takes attraction of each the jonesing you're doing with speculation. None of that 2, 3x, and the leverage and stuff. Just 1 spec volition bash it for you. I similar that attitude.

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) develops therapies for chronic endocrine and neurological diseases, including treatments for terrible hypoglycemia, superior periodic paralysis, and endogenous hypercortisolemia. In addition, it is processing a once-weekly subcutaneous injection for hypothyroidism, which is presently undergoing a signifier 3 objective trial.

While we admit the imaginable of XERS arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article